Latest news
72 patient multi-indication trial approved to fast track TRP-8803 commercialisation - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 14:26:12 GMTEntropy Neurodynamics Secures Ethics Approval for 72-Patient, Eight-Indication TRP-8803 Basket Study - KalkineKalkine · Tue, 04 Aug 2026 03:54:05 GMTEntropy secures ethics approval for multi-indication trial - The AustralianThe Australian · Tue, 04 Aug 2026 03:31:00 GMTAkebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:00:00 GMTFrom Signal To Strategy What Oncology Basket Trials Can Teach Clinical Development Teams - Clinical LeaderClinical Leader · Wed, 29 Jul 2026 07:45:55 GMT